U.S. Metals and Mining Stock News

NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness

NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist. See our latest analysis for NeoGenomics. The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...
NYSE:FIHL
NYSE:FIHLInsurance

A Look At Fidelis Insurance Holdings (FIHL) Valuation After Its Large Share Buyback Program Completion

What Fidelis Insurance Holdings’ completed buyback means for shareholders Fidelis Insurance Holdings (FIHL) has just wrapped up a sizeable buyback, repurchasing 18,823,327 shares for US$351.4 million, equal to 18.24% of its share base under a program launched in August 2025. From October 1, 2025 to March 3, 2026 alone, the company bought back 16,988,264 shares, or 16.49% of its stock, at a time when the shares most recently closed at US$18.95. See our latest analysis for Fidelis Insurance...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Did Silicon Labs’ In‑Tire Sensor Deal With BANF Just Shift Silicon Laboratories’ (SLAB) Investment Narrative?

Earlier this month, BANF announced a collaboration with Silicon Labs to integrate the ultra‑low‑power BG22 Bluetooth LE SoC and Secure Vault security into BANF’s new in‑tire, battery‑free sensor platform for autonomous and connected vehicles. By digitizing real‑time tire conditions with on‑tire data processing and wireless power transfer, the partnership turns tires into high‑value data sources for safety, fleet management, and future predictive services. We’ll now examine how embedding...
NasdaqGS:SVCO
NasdaqGS:SVCOSoftware

A Look At Silvaco Group (SVCO) Valuation After Earnings Beat And AI Segment Growth

Silvaco Group (SVCO) surprised the market with quarterly results that came in ahead of expectations, along with revenue guidance above earlier forecasts and cost cuts tracking better than management initially outlined. See our latest analysis for Silvaco Group. Silvaco Group’s recent earnings beat and upbeat guidance have been met with sharp share price momentum, with a 7 day share price return of 53.5% and a year to date share price return of 22%, even though the 1 year total shareholder...
NasdaqGM:NIU
NasdaqGM:NIUAuto

Niu Technologies (NasdaqGM:NIU) Q4 Loss After Q3 Profit Challenges Bullish Margin Narratives

Niu Technologies (NasdaqGM:NIU) closed out FY 2025 with fourth quarter revenue of C¥676.2 million and a basic EPS loss of C¥1.10, alongside trailing twelve month revenue of C¥4.3 billion and a basic EPS loss of C¥0.49. Over recent quarters the company has seen revenue range from C¥681.9 million to C¥1.7 billion, with quarterly basic EPS swinging between a loss of C¥0.49 and a profit of C¥1.02. This underscores how volatile earnings have been around a still unprofitable margin profile. See our...
NYSE:AXTA
NYSE:AXTAChemicals

Axalta Coating Systems (AXTA) Valuation After Earnings Miss And Weaker Revenue Guidance

Why Axalta Coating Systems (AXTA) Is Back Under Pressure Axalta Coating Systems (AXTA) has come under fresh scrutiny after underperforming in its latest quarter and guiding to a mid single digit revenue decline, alongside rising raw material costs and softer North American demand. See our latest analysis for Axalta Coating Systems. The Q4 2025 earnings miss and softer Q1 2026 outlook have been reflected in the share price, with a 30 day share price return showing an 18.17% decline and a 1...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Assessing Safety Insurance Group (SAFT) Valuation After Improved Combined Ratio And Dividend Strength

Safety Insurance Group (SAFT) is in focus after reporting an improved combined ratio of 99% in 2024, a well covered dividend, and a 4.2% yield on its investment portfolio. See our latest analysis for Safety Insurance Group. The share price sits at $73.53 after a 1 day share price return of 0.40% and a 7 day share price return of 1.21%. However, the 30 day share price return of 7.31% and year to date share price return of 2.88% point to fading short term momentum. The 3 year total shareholder...
NYSE:TSQ
NYSE:TSQMedia

Townsquare Media (TSQ) Returns To Loss In Q4 EPS Challenging Profit Recovery Narrative

Townsquare Media (TSQ) FY 2025 Earnings Snapshot Townsquare Media (TSQ) has wrapped up FY 2025 with Q4 revenue of US$106.5 million and a basic EPS loss of US$0.32, while trailing twelve month figures show revenue at US$427.4 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue move from US$117.8 million in Q4 2024 to US$106.5 million in Q4 2025, with EPS shifting from a profit of US$1.59 to a loss of US$0.32. This sets up a story where revenue is...
NYSE:NVST
NYSE:NVSTMedical Equipment

A Look At Envista Holdings (NVST) Valuation After Recent Share Price Volatility

Why Envista Holdings is on investors’ radar today Envista Holdings (NVST) is back in focus after recent trading, with the share price closing at $25.02 and short term returns mixed between a 1 day gain and a weaker past week. Over the past month the stock has recorded a 14% decline, while the past 3 months show a 14% total return, giving investors a compact snapshot of recent volatility and recovery. See our latest analysis for Envista Holdings. That recent 14.25% 3 month share price return...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Cytokinetics MYQORZO Data Sheds Light On oHCM Outlook And Valuation

Cytokinetics (NasdaqGS:CYTK) presented new clinical data on MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy at a major cardiology conference. The updates covered exercise capacity outcomes, effectiveness across patients with and without hypertension, and safety during treatment interruption and restart. The new analyses expand the clinical profile of MYQORZO, a recently approved oHCM therapy, and add detail on how the drug performs in real treatment scenarios. Cytokinetics...
NYSE:SFBS
NYSE:SFBSBanks

Is ServisFirst Bancshares (SFBS) Offering A Chance After Recent Share Price Weakness

Wondering whether ServisFirst Bancshares is attractively priced at its current level? This article focuses squarely on what the recent share performance might be telling you about value. The stock last closed at US$73.73, with returns of 2.7% year to date, a 14.4% decline over the past month, and a 9.7% decline over the past year, while still showing a 35.2% gain over three years and 31.1% over five years. These mixed returns have kept ServisFirst Bancshares on the radar for investors who...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Gold.com Board Shift Brings New Capital Markets Focus For Investors

Gold.com (NYSE:GOLD) has appointed Juan Sartori to its Board of Directors with immediate effect. The move coincides with the retirement of longtime director Beverley Lepine after more than a decade of service. Sartori brings experience in digital finance, commodities, and global capital markets to the company’s board. Gold.com, trading at $46.72, has seen a 34.4% return year to date and a 72.0% return over the past year, with longer term 3 year and 5 year returns of 74.1% and 183.2%...
NasdaqGS:FTDR
NasdaqGS:FTDRConsumer Services

Frontdoor (FTDR) Valuation Check After Strong Q4 Beat And Softer Full Year Guidance

Frontdoor (FTDR) is back in focus after reporting Q4 revenue of $433 million, a 13.1% year over year increase, along with earnings that exceeded expectations and full year revenue guidance slightly below projections. See our latest analysis for Frontdoor. Since the earnings release, Frontdoor’s share price has moved to US$64.22, with a 13.38% 1 month share price return and a 69.58% 1 year total shareholder return, which may suggest building momentum despite some recent short term pullback. If...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

Is United Bankshares (UBSI) Still Sensibly Priced After The Recent Share Price Pullback?

Wondering if United Bankshares at around US$39.38 is still a fair deal or starting to look stretched? This article breaks down what the current share price might be implying about value. The stock’s returns range from a 1.4% decline over the last 7 days and a 10.7% decline over the last 30 days, to gains of 2.6% year to date, 17.5% over 1 year, 25.7% over 3 years and 25.2% over 5 years. These figures can mean very different things depending on how you think about risk and timing. Recent...
NasdaqGS:ORLY
NasdaqGS:ORLYSpecialty Retail

O'Reilly Automotive Debt Issuance Raises Questions On Long Term Flexibility

O'Reilly Automotive completed a significant fixed income offering of senior unsecured notes due in 2036. The transaction adds long dated debt to the company’s balance sheet, which may affect its capital structure and liquidity profile. The terms of the notes and investor demand can offer clues about how credit markets currently view O'Reilly Automotive, ticker NasdaqGS:ORLY. Investors watching NasdaqGS:ORLY now have a fresh data point to consider alongside the current share price of $90.46...
NasdaqGM:TLS
NasdaqGM:TLSSoftware

Telos (TLS) Q4 Loss Rebound Challenges Bullish Margin Improvement Narratives

Telos (TLS) just closed out FY 2025 with Q4 revenue of US$46.8 million and a basic EPS loss of US$0.22, capping a year in which trailing twelve month revenue came in at US$164.8 million and EPS on the same basis was a loss of US$0.50. Over recent quarters the company has seen revenue move from US$26.4 million in Q4 2024 to US$30.6 million in Q1 2025, US$36.0 million in Q2, US$51.4 million in Q3, and US$46.8 million in Q4, while quarterly basic EPS losses ranged between US$0.03 and US$0.22...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

A Look At Waystar Holding (WAY) Valuation As Google Cloud AI Partnership Gains Traction

AI partnership expansion with Google Cloud comes into focus Waystar Holding (WAY) is back on investor radars after announcing an expanded collaboration with Google Cloud that centers on deeper use of Gemini AI models and data infrastructure in healthcare payments. The move targets more automation across complex revenue cycle workflows, including new agentic AI use cases that combine financial and clinical data, and could influence how investors think about the company’s long term technology...
NasdaqGS:ITRN
NasdaqGS:ITRNCommunications

Stronger Earnings And Bigger Capital Returns Could Be A Game Changer For Ituran (ITRN)

Ituran Location and Control Ltd. recently reported higher fourth‑quarter and full‑year 2025 earnings, approved a US$1.50 per‑share cash dividend totaling about US$30.00 million to be paid on April 16, 2026, and completed a US$25.42 million share buyback while authorizing an additional US$10.00 million for repurchases. The combination of earnings growth, a sizable dividend drawn from “Preferred Income” and “Preferred Technological Income” at a reduced 20% withholding tax rate, and an expanded...
NasdaqGS:LFCR
NasdaqGS:LFCRLife Sciences

Lifecore Biomedical (LFCR) Q4 Loss Narrows To US$2 Million Reinforcing Bullish Margin Narratives

Lifecore Biomedical (LFCR) just posted its FY 2025 fourth quarter numbers, with revenue of US$36.4 million and a basic EPS loss of US$0.06. This sets the tone for a year where the trailing twelve months show revenue at about US$129.5 million and a basic EPS loss of US$0.92. Over recent quarters, revenue has moved from US$24.7 million in Q1 FY 2025 to US$31.1 million in Q3 and then US$36.4 million in Q4. Quarterly basic EPS losses ranged from US$0.53 in Q1 to US$0.29 in Q3 and US$0.06 in Q4,...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

Assessing TriMas (TRS) Valuation After Recent Share Price Momentum And Undervaluation Narrative

Why TriMas is on investors’ radar today TriMas (TRS) has drawn fresh interest as investors look at its recent share performance alongside its value score of 3 and current market capitalization of about US$1.32b. The stock shows a 1 day return of 1.23%, a month return decline of 2.21%, and a past 3 months return of 3.77%, while the 1 year total return stands at 42.54%. See our latest analysis for TriMas. The recent 1 day share price gain of 1.23% to US$35.47 comes after a weaker 7 day and year...
NYSE:LTC
NYSE:LTCHealth Care REITs

Is LTC Properties (LTC) Offering Value After Strong Multi Year Share Price Gains

If you are wondering whether LTC Properties at around US$38.99 is offering good value today, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock has delivered a 0.6% return over the last week, a 1.0% decline over the past month, and is up 12.5% year to date and 15.5% over the past year, with longer term returns of 41.0% over three years and 26.1% over five years. Recent attention on LTC Properties has focused on its position...
NYSE:ED
NYSE:EDIntegrated Utilities

Does New US$3.5 Billion Credit Line And EPS Targets Change The Bull Case For Consolidated Edison (ED)?

Consolidated Edison recently entered into a new US$3.50 billions revolving credit facility to support its commercial paper programs and general corporate purposes, shortly after reporting Q4 2025 revenue and adjusted EPS that topped Wall Street expectations. Together with management’s plans for a five-year adjusted EPS compound annual growth rate of 6% to 7%, the expanded credit access highlights how the utility is prioritizing both liquidity and earnings visibility. We’ll now look at how...
NYSE:BEKE
NYSE:BEKEReal Estate

KE Holdings (NYSE:BEKE) Margin Compression Tests Premium P/E And Bullish Growth Narrative

KE Holdings (NYSE:BEKE) FY 2025 Results Overview KE Holdings (NYSE:BEKE) has wrapped up FY 2025 with fourth quarter revenue of C¥22.2b and basic EPS of C¥0.08, alongside trailing 12 month revenue of C¥94.6b and basic EPS of C¥2.70 that frame the latest print for investors watching the stock around C¥16.90 per share. The company has seen quarterly revenue range from C¥22.1b to C¥26.0b over the past year, with basic EPS moving between C¥0.08 and C¥1.16 across FY 2025. This gives a clearer view...